相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway
Tiffiney R. Hartman et al.
HUMAN MOLECULAR GENETICS (2009)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
Jingxiang Huang et al.
BIOCHEMICAL JOURNAL (2008)
Lymphangioleiomyomatosis - A clinical update
Francis X. McCormack
CHEST (2008)
The TSC1-TSC2 complex is required for proper activation of mTOR complex 2
Jingxiang Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation
Feng Hong et al.
MOLECULAR CELL (2008)
Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis
Lisa R. Young et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis
D. Mark Davies et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
John J. Bissler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity
Geraldine A. Finlay et al.
CANCER RESEARCH (2007)
Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration
Beibei Wu et al.
IMMUNITY (2007)
Molecular pathogenesis of lymphangioleiomyomatosis - Lessons learned from orphans
Stephen C. Juvet et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
Leming Shi et al.
NATURE BIOTECHNOLOGY (2006)
Rheb inhibits C-Raf activity and B-Raf/C-Raf heterodimerization
Magdalena Karbowniczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs
MA Moses et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-κB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin
Bysani Chandrasekar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Aberrant β-catenin signaling in tuberous sclerosis
BC Mak et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology
S Chakrabarti et al.
EXPERIMENTAL LUNG RESEARCH (2005)
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling - Potential implications in atherosclerosis and lymphangioleiomyomatosis
N Ferri et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways
J Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Lymphangiogenesis in lymphangioleiomyomatosis - Its implication in the progression of lymphangioleiomyomatosis
T Kumasaka et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent
M Karbowniczek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
AR Folgueras et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY (2004)
Tissue inhibitor of metalloproteinase-3 downregulation in lymphangioleiomyomatosis - Potential consequence of abnormal serum response factor expression
XN Zhe et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells
DJ Kwiatkowski et al.
HUMAN MOLECULAR GENETICS (2002)
Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury
MP Bendeck et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization
NE Sounni et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway
CJ Morrison et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis
J Yu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL) - Modulation of MMP-9 activity by NGAL
L Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis
T Carsillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model
JM Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy - An immunohistochemical study
K Matsui et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)